Palvella Therapeutics, Inc. (PVLA) Asset Utilization Ratio (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Asset Utilization Ratio for 11 consecutive years, with 1.64 as the latest value for Q3 2024.
- On a quarterly basis, Asset Utilization Ratio fell 474.63% to 1.64 in Q3 2024 year-over-year; TTM through Sep 2024 was 1.64, a 474.63% decrease, with the full-year FY2023 number at 0.08, down 61.75% from a year prior.
- Asset Utilization Ratio was 1.64 for Q3 2024 at Palvella Therapeutics, down from 1.22 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.47 in Q2 2020 to a low of 1.64 in Q3 2024.
- A 5-year average of 0.01 and a median of 0.21 in 2021 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: skyrocketed 110.94% in 2022, then crashed 477.42% in 2024.
- Palvella Therapeutics' Asset Utilization Ratio stood at 0.22 in 2020, then decreased by 8.72% to 0.2 in 2021, then skyrocketed by 34.58% to 0.27 in 2022, then tumbled by 227.62% to 0.34 in 2023, then plummeted by 383.33% to 1.64 in 2024.
- Per Business Quant, the three most recent readings for PVLA's Asset Utilization Ratio are 1.64 (Q3 2024), 1.22 (Q2 2024), and 0.72 (Q1 2024).